Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
Trump nominated Gabbard to serve as director of national intelligence, raising concerns among some former national security officials.

K Street, Capitol Hill cast doubt on Gabbard’s confirmation

The Senate is already conducting confirmation hearings for Trump administration nominees, with some sparking fireworks.

One nominee in particular could be in trouble, according to respondents to our Canvass Inauguration Special survey: Former Rep. Tulsi Gabbard (Hawaii). More than two-thirds of senior Capitol Hill staff and K Street leaders we polled said Gabbard will not be confirmed.

President-elect Donald Trump nominated Gabbard to serve as director of national intelligence, raising concerns among some former national security officials. Of all the Trump nominees, Gabbard is the only one whom a majority of respondents believe won’t make it across the finish line.

Just 34% said Pete Hegseth wouldn’t be confirmed as Defense secretary and 33% said the same of Kash Patel as FBI director. Similarly, only 25% of respondents said Robert F. Kennedy Jr. wouldn’t be confirmed as secretary of Health and Human Services.

Hegseth could be confirmed later this week.

As we’ve reported, the Senate Intelligence Committee hasn’t yet scheduled Gabbard’s confirmation hearing, citing paperwork delays that are plaguing other Trump nominees, too.

Paperwork aside, lawmakers have voiced grave concerns about Gabbard, including her past opposition to Section 702 of the Foreign Intelligence Surveillance Act. Gabbard released a statement to us backing the program after senators from both parties were questioning her position.

With a tiny Republican majority in the Intelligence Committee, Gabbard cannot afford to lose any GOP support in the panel. It’s very unlikely any Democrats would vote to advance her nomination out of committee.

Want to take part in The Canvass? Our survey provides anonymous monthly insights from top Capitol Hill staffers and K Street leaders on key issues Washington is dealing with. Sign up here if you work on K Street. Click here to sign up if you’re a senior congressional staffer.

Presented by Pharmaceutical Reform Alliance

Americans know who to blame for rising drug prices: Big Pharma. A majority of Republicans, Democrats, & Independents all believe Big Pharma’s focus on profits keeps drug prices high. Let’s hold Big Pharma accountable – it’s an issue we’re united on.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.